Covered recipient · General Payments record
FELICE R ZWAS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$5,362.57
- Reported across 313 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $624.50 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $261.99 | 15 |
| PFIZER INC. | $152.14 | 11 |
| Ardelyx, Inc. | $51.35 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.82 | 1 |
| Madrigal Pharmaceuticals | $30.25 | 1 |
| Celgene Corporation | $25.45 | 1 |
| Janssen Biotech, Inc. | $24.78 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $23.54 | 1 |
| Lilly USA, LLC | $22.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.18 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402595 | CMS |
| ABBVIE INC. | $10.78 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402597 | CMS |
| ABBVIE INC. | $2.81 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402599 | CMS |
| ABBVIE INC. | $11.68 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402601 | CMS |
| ABBVIE INC. | $15.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402603 | CMS |
| ABBVIE INC. | $5.77 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402605 | CMS |
| ABBVIE INC. | $29.25 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402607 | CMS |
| ABBVIE INC. | $31.36 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402609 | CMS |
| ABBVIE INC. | $29.20 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402611 | CMS |
| ABBVIE INC. | $27.18 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402613 | CMS |
| ABBVIE INC. | $22.24 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402615 | CMS |
| ABBVIE INC. | $12.07 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402617 | CMS |
| ABBVIE INC. | $16.24 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402619 | CMS |
| ABBVIE INC. | $14.82 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402621 | CMS |
| ABBVIE INC. | $25.93 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106402623 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $23.54 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146978940 | CMS |
| Ardelyx, Inc. | $26.23 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146715867 | CMS |
| Ardelyx, Inc. | $25.12 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146715869 | CMS |
| Celgene Corporation | $25.45 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101105972 | CMS |
| Janssen Biotech, Inc. | $24.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078376016 | CMS |
| Lilly USA, LLC | $22.18 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976160 | CMS |
| Madrigal Pharmaceuticals | $30.25 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144186373 | CMS |
| PFIZER INC. | $2.32 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131248005 | CMS |
| PFIZER INC. | $5.13 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131248009 | CMS |
| PFIZER INC. | $1.26 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130901889 | CMS |
| PFIZER INC. | $21.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131351474 | CMS |
| PFIZER INC. | $22.27 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441182 | CMS |
| PFIZER INC. | $3.89 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130929020 | CMS |
| PFIZER INC. | $21.48 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131846917 | CMS |
| PFIZER INC. | $22.33 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132079005 | CMS |
| PFIZER INC. | $22.68 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131007651 | CMS |
| PFIZER INC. | $5.99 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131090017 | CMS |
| PFIZER INC. | $22.81 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131180169 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.82 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137703579 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.